Trademark: 87872234
Status Date
Tuesday, May 12, 2020
Registration Number
6055219
Registration Date
Tuesday, May 12, 2020
Filing Date
Wednesday, April 11, 2018
5 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Apr 28, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 28, 2021
Teas Change Of Correspondence Received
Apr 28, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 28, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 28, 2021
Teas Change Of Owner Address Received
Aug 7, 2020
Teas Change Of Correspondence Received
Aug 7, 2020
Teas Change Of Domestic Representatives Address
Aug 7, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 7, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 5, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 5, 2020
Teas Change Of Correspondence Received
Aug 5, 2020
Teas Change Of Domestic Representatives Address
Aug 5, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 5, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 5, 2020
Teas Change Of Owner Address Received
May 12, 2020
Registered-Supplemental Register
Apr 9, 2020
Law Office Publication Review Completed
Apr 2, 2020
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Apr 1, 2020
Exparte Appeal Terminated
Apr 1, 2020
Approved For Registration Supplemental Register
Apr 1, 2020
Use Amendment Accepted
Mar 26, 2020
Amendment To Use Processing Complete
Mar 26, 2020
Use Amendment Filed
Mar 26, 2020
Teas/Email Correspondence Entered
Mar 26, 2020
Correspondence Received In Law Office
Mar 25, 2020
Teas Amendment Of Use Received
Mar 25, 2020
Teas Request For Reconsideration Received
Mar 25, 2020
Ex Parte Appeal-Instituted
Mar 25, 2020
Jurisdiction Restored To Examining Attorney
Mar 25, 2020
Exparte Appeal Received At Ttab
Sep 27, 2019
Notification Of Final Refusal Emailed
Sep 27, 2019
Final Refusal E-Mailed
Sep 27, 2019
Final Refusal Written
Sep 17, 2019
Teas/Email Correspondence Entered
Sep 17, 2019
Correspondence Received In Law Office
Sep 13, 2019
Teas Response To Office Action Received
Apr 26, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 26, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 13, 2019
Notification Of Non-Final Action E-Mailed
Mar 13, 2019
Non-Final Action E-Mailed
Mar 13, 2019
Non-Final Action Written
Feb 21, 2019
Divisional Processing Complete
Feb 7, 2019
Divisional Request Received
Feb 21, 2019
Teas/Email Correspondence Entered
Feb 7, 2019
Correspondence Received In Law Office
Feb 13, 2019
Case Assigned To Intent To Use Paralegal
Feb 12, 2019
Assigned To Lie
Feb 7, 2019
Teas Response To Office Action Received
Feb 7, 2019
Teas Request To Divide Received
Aug 7, 2018
Notification Of Non-Final Action E-Mailed
Aug 7, 2018
Non-Final Action E-Mailed
Aug 7, 2018
Non-Final Action Written
Jul 31, 2018
Assigned To Examiner
Apr 19, 2018
New Application Office Supplied Data Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
